Lifestyle intervention shows promise, but experts warn more research needed
A major cardiovascular trial demonstrates that comprehensive lifestyle changes can slow disease progression in at-risk patients. However, researchers caution that the findings raise new questions about optimal prevention strategies, potentially reshaping how insurers and health systems allocate resources for disease prevention programs.
Originaltitel: The TANSNIP-PESA trial is not the end of the story
<p>This commentary refers to 'Effects of a comprehensive lifestyle intervention on cardiovascular health: the TANSNIP-PESA trial', by I. Garcia-Lunar et al., https://doi.org/10.1093/eurheartj/ehac378 and the discussion piece 'Motivational interview and imaging of subclinical atherosclerosis for cardiovascular disease prevention: a winning combination?', by I. Garcia-Lunar et al., https://doi.org/10.1093/eurheartj/ehad126.</p>